LIFE360 INC (360)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

360 - LIFE360 INC

FNArena Sector : Software & Services
Year End: December
GICS Industry Group : Software & Services
Debt/EBITDA: -0.34
Index: ASX200 | ASX300 | ALL-ORDS | ALL-TECH

Life360 Inc is a San Francisco based software technology company providing real time location sharing apps which allow users to view their contact's location and communicate with them. The company listed on the ASX in 2019.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$22.59

23 Dec
2024

0.590

OPEN

$22.17

2.68%

HIGH

$22.77

482,243

LOW

$22.06

TARGET
$24.963 10.5% upside
Franking for last dividend paid out: 0%
OTHER COMPANIES IN THE SAME SECTOR
ADA . AHI . ALC . AMX . ATA . BMT . COS . DOC . EVS . GTK . KYP . NET . NXL . QOR . RDY . SKO . UBN . VGL . XF1 . YOJ . Z2U .
FNARENA'S MARKET CONSENSUS FORECASTS
360: 1
Title FY24
Forecast		 FY25
Forecast
EPS (cps) 34.1 xxx
DPS (cps) 0.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 65.3 xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx-21.2
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx458.8 M
Book Value Per Share xxxxxxxxxxxxxxx177.1
Net Operating Cash Flow xxxxxxxxxxxxxxx11.3 M
Net Profit Margin xxxxxxxxxxxxxxx-9.25 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx-11.74 %
Return on Invested Capital xxxxxxxxxxxxxxx-11.60 %
Return on Assets xxxxxxxxxxxxxxx-6.65 %
Return on Equity xxxxxxxxxxxxxxx-11.74 %
Return on Total Capital xxxxxxxxxxxxxxx-10.52 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx10.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx6 M
Long Term Debt xxxxxxxxxxxxxxx3 M
Total Debt xxxxxxxxxxxxxxx8 M
Goodwill - Gross xxxxxxxxxxxxxxx196 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx101 M
Price To Book Value xxxxxxxxxxxxxxx4.27

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx3.3 M
Capex % of Sales xxxxxxxxxxxxxxx0.73 %
Cost of Goods Sold xxxxxxxxxxxxxxx123 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx375 M
Research & Development xxxxxxxxxxxxxxx149 M
Investments - Total xxxxxxxxxxxxxxx11 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.8

No. Of Recommendations

4
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

14/11/2024

3

Neutral

-

-

Target price has gained US$2 to US$52 and UBS has retained its Neutral rating for Life360. Management has lowered its revenue guidance for FY24 following Q3, but the broker is not worried about it.

UBS's advice for investors is keep the focus on the strength in subscriptions and the potential from advertising. The price target increase can function as a signal for the broker's ongoing confidence.

FORECAST
UBS forecasts a full year FY24 dividend of 0.00 cents and EPS of 84.72 cents.
UBS forecasts a full year FY25 dividend of 0.00 cents and EPS of 121.03 cents.

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Goldman Sachs

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Canaccord Genuity

15/08/2024

1

Buy

-

-

Canaccord Genuity observes Life360 reported "solid" results for the 2Q2024 and the first as a listed US company.

Monthly active users advanced to around 70.6m, some 2% above consensus and meeting the broker's expectations.

Paying circles, revenue were better than consensus forecasts.

Management's updated 2024 guidance was higher than anticipated. Canaccord Genuity raises the EPS forecasts by 5.5% for 2024 and 24.2% for 2025.

Target price is US$40, unchanged with a Buy rating.

FORECAST
Canaccord Genuity forecasts a full year FY24 EPS of minus -0.44 cents.
Canaccord Genuity forecasts a full year FY25 EPS of 0.17 cents.
Access Extra Coverage Research History >

360 STOCK CHART

FNArena News on 360

1
Rudi’s View: Final Best Buys & Conviction Ideas

Dec 23 2024 - Rudi's View
2
Rudi’s View: Banks, WiseTech, Redox & Integral Diagnostics

Dec 19 2024 - Rudi's View
3
Rudi’s View: Best Buys & Smaller Cap Favourites

Dec 12 2024 - Rudi's View
4
Rudi’s View: In Santa We Trust (?)

Dec 05 2024 - Rudi's View
5
Rudi’s View: Trump Beneficiaries & TechOne

Nov 28 2024 - Rudi's View

Latest Software & Services News

1
Pro Medicus, A Global Software Super Star

Dec 19 2024 - Australia
2
Higher Margins Underpin Gentrack’s Ambitions

Nov 28 2024 - Small Caps
3
Targets Jump For Embattled WiseTech

Nov 28 2024 - Australia
4
Nuix Rises From The Ashes

Nov 08 2024 - Small Caps
5
WiseTech In Global Supply Chain Sweet Spot

Oct 10 2024 - Australia
6
Quality By Any Objective Measure

Oct 04 2024 - Small Caps
7
Gen.Ai: Infrastructure Arms Race Powers Ahead

Sep 16 2024 - International
8
Gentrack Shares Breaking Out

Sep 10 2024 - Technicals
9
NextDC: Building A Generative AI Future 

Sep 09 2024 - Australia
10
In Brief: More US Millionaires & More From ECB

Jul 19 2024 - Weekly Reports